Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• Pediatric Endocrinologist Workforce Capacity Varies Widely By State
• Indiana Medicaid To Cover GLP-1 Obesity Medications Through Federal BALANCE Model
• Oncology Hospital-At-Home Program Reduced Six-Month Health Care Costs By Over $8,000 Per Consumer
• Neurocrine Biosciences Completes $2.9 Billion Acquisition Of Soleno Therapeutics To Add A Treatment For Prader-Willi Syndrome To Its Portfolio
• The New Age Of Care Coordination: A Discussion With Jeff Smith, CEO Of Bamboo Health
• Moving From Acute To Chronic 
• Amazon Pharmacy Starts $50 GLP-1 Delivery For Medicare Beneficiaries
• MOUD Associated With 89% Lower 30-Day Mortality Risk For Endocarditis In Injection Drug Users
• Nearly 500,000 Americans With Diabetes Projected To Lose Medicaid Coverage By 2034
• FDA Approves Eli Lilly’s Foundayo (Orforglipron) GLP-1 Pill For Weight Loss
• Abbott & Google Launch First-Of-Its-Kind Partnership To Transform Everyday Health Through Glucose Insights & AI
• Focus Health’s Irving, Texas Health & Wellness Clinic Expands Medical Weight Loss Program To Include Multiple New Wellness Treatments
• Treating Obesity & Type 2 Diabetes Reduced Kidney Disease By 62%
• Resilience Care Expands Digital Oncology Platform To The United States
• Managing The Overlap

See All

Treating Obesity & Type 2 Diabetes Reduced Kidney Disease By 62%

Participants in a metabolic care program for type 2 diabetes and obesity/overweight had a 36% lower risk of developing chronic kidney disease (CKD) compared to a matched group who received usual care. Participants also had a 43% lower risk of developing CKD stage 3 or higher and a 62% lower risk of developing CKD stage 4 or higher. The study involved the Virta Health Individualized Nutrition Therapy (VINT) program. VINT is a remotely administered metabolic… Read

• Medicaid Subscription-Based Payment Models For Hep C Drugs In Louisiana & Washington State Had A Larger Impact In Louisiana Due To Policy Factors
• Sempre Health Expands Chronic Condition Medication Management Program To Include Generics
• Navigate Launches Health Dashboard, A Member Care Engagement Platform For Employer Plans
• Global Parkinson’s Disease Genetics Study Finds 26% Of Cases Were Among Populations Under-Represented In Other Research
• Cardinal Health Announces Agreements To Acquire Strive Medical & AdaptHealth’s Diabetes Health Business

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.